510(k) Report

510(k) · Cleared

Cleared

Guava EZCD4 System

K053497510(k) TraditionalCleared Apr 14, 2006120-day reviewClass II21 CFR 864.5220

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Guava Technologies, Inc. · GKZ Counter, Differential Cell

Cleared on Apr 14, 2006 as substantially equivalent to K974360 (Becton Dickinson Immunocytometry Systems, 1998) and 1 other predicate after a 120-day review. Its family tree reaches back 3 generations to 1996.

Decided
Apr 14, 2006
Review
120 days
Class
Class II
Product code
GKZ
Recalls
None
Predicates
2

Its longest line of descent runs back 3 generations to K946055 (1996). 8 ancestors in all, the oldest K913192 (1992). No later device cites it as a predicate yet.

  1. Root · 3 generations backK946055 Tritest Reagent CD3 Fitc/CD4 PE/CD45 PercpBecton Dickinson Immunocytometry Systems · 1996 · Recalled
  2. 2 generations backK963963 Multiset Software for Automated Flow Cytometric Data AnalysisBecton Dickinson Immunocytometry Systems · 1996 · Recalled
  3. 1 generation backK974360 Multitest CD3/CD8/CD45/CD4Becton Dickinson Immunocytometry Systems · 1998
  4. This deviceK053497 Guava EZCD4 SystemGuava Technologies, Inc. · 2006
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K946055Tritest Reagent CD3 Fitc/CD4 PE/CD45 PercpBecton Dickinson Immunocytometry Systems19961
−2K963963Multiset Software for Automated Flow Cytometric Data AnalysisBecton Dickinson Immunocytometry Systems19961
−1K974360Multitest CD3/CD8/CD45/CD4Becton Dickinson Immunocytometry Systems1998—
0 (this device)K053497Guava EZCD4 SystemGuava Technologies, Inc.2006—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199210
199410
199730
FIG. 1 — Lineage of K053497, 1996–2006Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GKZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GKZ device

  1. #1 K250943 Sysmex XR-Series (XR-10) Automated Hematology…score 13.2 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K974360Multitest CD3/CD8/CD45/CD4
Summary page 1
…Class II Predicate Devices: The Guava EZCD4 Assay is substantially equivalent to the Becton Dickinson MultiTest CD3 FITC / CD8 PE/CD45 PerCP/CD4 APC Reagent (K974360) and TriTest CD3 FITC/ CD4 PE/ CD45 PerCP Reagent (K965053) when performed on the FACSCalibur. Description of Device: Determina…
Becton Dickinson Immunocytometry Systems1998—
*K965053Tritest Reagent CD3 Fitc/CD4 PE/CD45 Percp; Trucount Absolute Count Tubes
Summary page 1
…ay is substantially equivalent to the Becton Dickinson MultiTest CD3 FITC / CD8 PE/CD45 PerCP/CD4 APC Reagent (K974360) and TriTest CD3 FITC/ CD4 PE/ CD45 PerCP Reagent (K965053) when performed on the FACSCalibur. Description of Device: Determination of the absolute number of CD4 + T cells circulating in…
Becton Dickinson Immunocytometry Systems1997—

Also cleared against K974360: 6 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 10 years and passes through 2 companies; a new generation was cleared every 1.2 years on median.
  • 4 of the 8 ancestors have a recall of any class.
  • 6 other devices also cite its predicate K974360.

How does its category compare?

All GKZ devices

GKZ Counter, Differential Cell: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GKZ

4in 2025

2007: 62008: 62009: 62010: 42011: 32012: 32013: 12014: 32015: 32016: 32017: 42018: 32019: 52020: 12022: 32023: 42024: 32025: 42026 (partial year): 4
2007high 6 (2007) · low 0 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GKZ

108in 2025

2007: 117 days median2008: 99 days median2009: 147 days median2010: 290 days median2011: 315 days median2012: 408 days median2014: 165 days median2015: 273 days median2016: 198 days median2017: 280 days median2018: 270 days median2019: 210 days median2022: 638 days median2023: 329 days median2024: 157 days median2025: 108 days median2026 (partial year): 254 days median
2007high 638 (2022) · low 99 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GKZ

1in 2025

2007: 372008: 52009: 132010: 272011: 282012: 72013: 62015: 32016: 32017: 32018: 2, 2 Class I2019: 22020: 12022: 42023: 12025: 1
2007high 37 (2007) · low 0 (2014)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · GKZ

77in 2025

2007: 2682008: 9252009: 5592010: 8962011: 2,9052012: 2,9592013: 3,0702014: 3,1122015: 1,9722016: 3,3382017: 2292018: 4972019: 9082020: 3422021: 3912022: 1982023: 1552024: 1152025: 77
2007high 3,338 (2016) · low 77 (2025)2025

MAUDE reports naming product code GKZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007611737268
20086995925
2009614713559
2010429027896
20113315282,905
2012340872,959
20131—63,070
2014316503,112
2015327331,972
2016319833,338
201742803229
201832702 (2)497
201952102908
20201—1342
20210—0391
202236384198
202343291155
202431570115
20254108177
202642540—

What is it indicated for?

The EZCD4 Assay is intended to be performed on a Guava PCA System with CytoSoft 2.3 version software which includes three modules; EZCD4, Guava Check and Clean and Shutdown. The system is intended to identify and quantify the absolute counts of CD4 T-Lymphocytes in EDTA whole blood. The GuavaEZCD4 system is intended for the ongoing monitoring of patients with documented diagnosis of an immunodeficiency disease. The Guava EZCD4 system is intended for use only by trained laboratory professionals.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K053497: Guava EZCD4 System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K053497

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026